首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Prothrombotic state in senile patients with acute exacerbations of chronic obstructive pulmonary disease combined with respiratory failure
【2h】

Prothrombotic state in senile patients with acute exacerbations of chronic obstructive pulmonary disease combined with respiratory failure

机译:老年慢性阻塞性肺疾病急性加重合并呼吸衰竭患者的血栓形成状态

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to study the clinical value of prethrombotic state and treatment with low molecular weight heparin (LMWH) in senile patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) combined with respiratory failure. Hemorheological markers (hematocrit, blood viscosity and plasma viscosity), fibrinogen (FIB), D-dimer and gas analysis were evaluated in 30 senile patients with AECOPD combined with respiratory failure and compared with those in 30 cases without respiratory failure. A total of 30 cases with AECOPD combined with respiratory failure were randomly divided into treatment and control groups. The two groups received conventional treatment. The treatment group also received LMWH injections every 12 h for 6 days and the clinical effect was observed. The levels of FIB, D-dimer, hematocrit, blood viscosity and plasma viscosity were significantly higher in the patients with AECOPD combined with respiratory failure compared with those in the patients without respiratory failure. The plasma D-dimer and FIB levels had significantly positive correlations with the partial pressure of CO2 (PaCO2) and negative correlations with the partial pressure of O2 (PaO2) in the patients with AECOPD combined with respiratory failure. The curative effect was improved in the treatment group, compared with that in the control group without side-effects. However, no significant changes in activated partial thromboplastin time (APTT) and international normalized ratio (INR) were observed between the treatment and control groups. The senile patients with AECOPD combined with respiratory failure suffered from hypercoagulation. Early detection and diagnosis of the prethrombotic state and timely treatment with LMWH may benefit these patients without side-effects.
机译:这项研究的目的是研究血栓前状态和低分子量肝素(LMWH)治疗在患有慢性阻塞性肺疾病急性加重并发呼吸衰竭的老年患者中的临床价值。评价了30例AECOPD合并呼吸衰竭的老年患者的血液流变学指标(血细胞比容,血液粘度和血浆粘度),纤维蛋白原(FIB),D-二聚体和气体分析,并与30例无呼吸衰竭的患者进行了比较。共有30例AECOPD合并呼吸衰竭的患者随机分为治疗组和对照组。两组均接受常规治疗。治疗组还每12小时接受LMWH注射6天,并观察到临床效果。 AECOPD合并呼吸衰竭的患者的FIB,D-二聚体,血细胞比容,血液粘度和血浆粘度显着高于无呼吸衰竭的患者。 AECOPD合并呼吸衰竭的患者血浆D-二聚体和FIB水平与CO2分压(PaCO2)呈显着正相关,与O2分压(PaO2)呈负相关。与无副作用的对照组相比,治疗组的疗效得到改善。但是,在治疗组和对照组之间,未观察到活化的部分凝血活酶时间(APTT)和国际标准化比率(INR)的显着变化。 AECOPD合并呼吸衰竭的老年患者患有高凝。早期发现和诊断血栓前状态并及时用LMWH治疗可能会使这些患者受益,而没有副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号